CDH2 and cholangiocarcinoma: MiR-329 facilitates EMT in CCA cells by decreasing E-cadherin levels while increasing the expression of N-cadherin and Vimentin; furthermore, the interaction between miR-329 and LAMB3 elucidates its pivotal role in modulating EMT processes [44].